Recently, clinical NGS tests using targeted gene panels or whole exome sequencing (WES) have been used to identify pathogenic sequence mutations including single nucleotide variations (SNVs) and small insertion-deletions (indels) in both adult6,7,8 and pediatric cancer studies8,9,10.
All mutations, including single mutations, were included in this calculation.
A wide variety of mutations, including single base pair changes, can cause the null phenotypes attained in this work through transposon insertions and gene replacements.
These structures can be significantly disrupted by mutations including Single Nucleotide Polymorphisms (SNPs) [ 11, 12].
Twenty-two mutatincludedluded single nucleotide substitutions, resulting in silent, missense, or nonsense mutations, and deletions and insertions of as many as 234 nucleotides.
Currently it is possible to comprehensively identify genetic mutations, including single base changes, deletions, insertions and genomic rearrangements in early events for AML/MDS development.
The patients were all diagnosed with adult onset Hereditary Spastic Paraplegia by a neurologist (CS) and in each case a mutation in SPAST was identified: the mutations included single nucleotide substitutions, insertions and deletions (Abrahamsen et al., 2013).
We performed an exome-wide study of somatic mutations, including single nucleotide variants (SNVs) and short insertions and deletions (indels), from 100 colon adenocarcinoma patients obtained from The Cancer Genome Atlas (TCGA) project [ 16].
Five hundred tumor genomes, as well as matched normal control genomes for each cancer type, will be analyzed using high-throughput next-generation sequencing technologies to detect a wide range of somatic mutations, including single nucleotide mutations, small insertions/deletions, copy number alterations, translocations and other chromosomal structural rearrangements.
We detected newly selected mutations, including single-nucleotide polymorphisms (SNPs), copy-number variations and loss-of-heterozygosity (LOH) events.
